(Mark One) | |
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) | |||||
300 East Lombard Street, Suite 1710 | ||||||
(Zip Code) | ||||||
(Address of principal executive office (US)) | ||||||
(Registrant's telephone number, including area code) | ||||||
Securities registered pursuant to section 12(b) of the Act | ||||||
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||
☑ | Accelerated filer | ☐ | ||
Non-accelerated filer | ☐ | Smaller reporting company | ||
Emerging growth company |
Page | |||
Item 1. | |||
Item 2. | |||
Item 3. | |||
Item 4. | |||
Item 1. | |||
Item 1A. | |||
Item 2. | |||
Item 3. | |||
Item 4. | |||
Item 5. | |||
Item 6. | |||
Three months ended June 30, | Six months ended June 30, | |||||||||
(in millions of U.S. dollars) | Notes | 2026 | 2025 | 2026 | 2025 | |||||
Revenue | 2 | |||||||||
Cost of sales (excluding depreciation and amortization) | ( | ( | ( | ( | ||||||
Depreciation and amortization | ( | ( | ( | ( | ||||||
Selling and administrative expenses | ( | ( | ( | ( | ||||||
Research and development expenses | ( | ( | ( | ( | ||||||
Other gains and losses – net | 4 | ( | ( | |||||||
Finance costs – net | 5 | ( | ( | ( | ( | |||||
Income before tax | ||||||||||
Income tax expense | 6 | ( | ( | ( | ( | |||||
Net income | ||||||||||
Attributable to: | ||||||||||
Equity holders of Constellium SE | ||||||||||
Non-controlling interests | ( | |||||||||
Net income | ||||||||||
Earnings per share attributable to the equity holders of Constellium SE (in U.S. dollars) | Notes | |||||||||
Basic | 7 | |||||||||
Diluted | 7 |
Three months ended June 30, | Six months ended June 30, | |||||||||
(in millions of U.S. dollars) | Notes | 2026 | 2025 | 2026 | 2025 | |||||
Net income | ||||||||||
Other comprehensive (loss) / income | ||||||||||
Net change in post-employment benefit obligations | ( | ( | ( | |||||||
Income tax on net change in post- employment benefit obligations | ( | |||||||||
Net change in cash flow hedges | 12 | ( | ( | |||||||
Income tax on cash flow hedges | ( | ( | ||||||||
Currency translation adjustments | ( | ( | ||||||||
Other comprehensive (loss) / income | ( | ( | ||||||||
Total comprehensive income | ||||||||||
Attributable to: | ||||||||||
Equity holders of Constellium SE | ||||||||||
Non-controlling interests | ( | |||||||||
Total comprehensive income | ||||||||||
(in millions of U.S. dollars) except share data and as otherwise stated | Notes | At June 30, 2026 | At December 31, 2025 | |||
Assets | ||||||
Current assets | ||||||
Cash and cash equivalents | ||||||
Trade receivables and other, net | 8 | |||||
Inventories | 9 | |||||
Fair value of derivative instruments and other financial assets | ||||||
Total current assets | ||||||
Non-current assets | ||||||
Property, plant and equipment, net | ||||||
Goodwill | ||||||
Intangible assets, net | ||||||
Deferred tax assets | ||||||
Trade receivables and other, net | 8 | |||||
Fair value of derivative instruments | 12 | |||||
Total non-current assets | ||||||
Total assets | ||||||
Liabilities | ||||||
Current liabilities | ||||||
Trade payables and other | 10 | |||||
Current portion of long-term debt | 11 | |||||
Fair value of derivative instruments | 12 | |||||
Income tax payable | ||||||
Pension and other benefit obligations | ||||||
Provisions | 14 | |||||
Total current liabilities | ||||||
Non-current liabilities | ||||||
Trade payables and other | 10 | |||||
Long-term debt | 11 | |||||
Fair value of derivative instruments | 12 | |||||
Pension and other benefit obligations | ||||||
Provisions | 14 | |||||
Deferred tax liabilities | ||||||
Total non-current liabilities | ||||||
Total liabilities | ||||||
Commitments and contingencies | 14 | |||||
Shareholders' equity | ||||||
Ordinary shares, par value € December 31, 2025; 2026 and at December 31, 2025, respectively | ||||||
Additional paid in capital | ||||||
Accumulated other comprehensive income | 15 | |||||
Retained earnings | ||||||
Treasury shares | ( | ( | ||||
Equity attributable to equity holders of Constellium SE | ||||||
Non-controlling interests | ||||||
Total equity | ||||||
Total equity and liabilities |
in millions of U.S. dollars, except share amounts | Ordinary shares outstanding | Ordinary shares | Treasury shares | Accumulated other comprehensive income / (loss) | Additional paid in capital | Retained earnings | Non- controlling interests | Total equity | ||||||||
At January 1, 2026 | ( | |||||||||||||||
Net income | — | — | — | — | — | ( | ||||||||||
Other comprehensive income | — | — | — | ( | — | — | — | ( | ||||||||
Total comprehensive income | — | — | — | ( | — | ( | ||||||||||
Share-based compensation | — | — | — | — | — | — | ||||||||||
Repurchase of ordinary shares | ( | — | ( | — | — | — | — | ( | ||||||||
Allocation of treasury shares to share-based compensation plan vested | — | — | — | ( | — | |||||||||||
Transactions with non- controlling interests | — | — | — | — | — | — | ( | ( | ||||||||
At March 31, 2026 | ( | |||||||||||||||
Net income | — | — | — | — | — | |||||||||||
Other comprehensive loss | — | — | — | ( | — | — | — | ( | ||||||||
Total comprehensive (loss) / income | — | — | — | ( | — | |||||||||||
Share-based compensation | — | — | — | — | — | — | ||||||||||
Repurchase of ordinary shares | ( | — | ( | — | — | — | — | ( | ||||||||
Allocation of treasury shares to share-based compensation plan vested | — | — | — | — | — | — | — | |||||||||
Other | — | — | — | — | ( | ( | ( | |||||||||
Transactions with non- controlling interests | — | — | — | — | — | — | ( | ( | ||||||||
At June 30, 2026 | ( | |||||||||||||||
in millions of U.S. dollars, except share amounts | Ordinary shares outstanding | Ordinary shares | Treasury shares | Accumulated other comprehensive income / (loss) | Additional paid in capital | Retained earnings | Non- controlling interests | Total equity | ||||||||
At January 1, 2025 | ( | ( | ||||||||||||||
Net income | — | — | — | — | — | |||||||||||
Other comprehensive loss | — | — | — | — | — | — | ||||||||||
Total comprehensive (loss) / income | — | — | — | — | ||||||||||||
Share-based compensation | — | — | — | — | — | — | ||||||||||
Repurchase of ordinary shares | ( | — | ( | — | — | — | — | ( | ||||||||
Allocation of treasury shares to share-based compensation plan vested | — | — | — | ( | — | |||||||||||
Other | — | — | — | — | ( | — | ||||||||||
Transactions with non- controlling interests | — | — | — | — | — | — | ( | ( | ||||||||
At March 31, 2025 | ( | ( | ||||||||||||||
Net income | — | — | — | — | — | — | ||||||||||
Other comprehensive income | — | — | — | — | — | |||||||||||
Total comprehensive income | — | — | — | — | ||||||||||||
Share-based compensation | — | — | — | — | — | — | ||||||||||
Repurchase of ordinary shares | ( | — | ( | — | — | — | — | ( | ||||||||
Allocation of treasury shares to share-based compensation plan vested | — | — | — | — | — | — | — | |||||||||
Other | — | — | — | — | — | — | — | |||||||||
Transactions with non- controlling interests | — | — | — | — | — | — | ( | ( | ||||||||
At June 30, 2025 | ( | |||||||||||||||
Three months ended June 30, | Six months ended June 30, | |||||||||
(in millions of U.S. dollars) | Notes | 2026 | 2025 | 2026 | 2025 | |||||
Net income | ||||||||||
Adjustments | ||||||||||
Depreciation and amortization | 3 | |||||||||
Impairment of assets | 3 | ( | ||||||||
Pension and other long-term benefits | ||||||||||
Finance costs - net | 5 | |||||||||
Income tax expense | ||||||||||
Unrealized losses / (gains) on derivatives - net and from remeasurement of monetary assets and liabilities - net | ( | ( | ||||||||
Losses on disposal | 4 | |||||||||
Other - net | ||||||||||
Changes in working capital | ||||||||||
Inventories | ( | ( | ( | |||||||
Trade receivables | ( | ( | ( | |||||||
Trade payables | ( | |||||||||
Other | ( | |||||||||
Change in provisions | ( | ( | ( | ( | ||||||
Pension and other long-term benefits paid | ( | ( | ( | ( | ||||||
Interest paid | ( | ( | ( | ( | ||||||
Income tax paid | ( | ( | ( | |||||||
Net cash flows from operating activities | ||||||||||
Purchases of property, plant and equipment | 3 | ( | ( | ( | ( | |||||
Property, plant and equipment inflows | 3 | |||||||||
Collection of deferred purchase price receivable | 8 | |||||||||
Proceeds from disposals, net of cash | ||||||||||
Other investing activities | ||||||||||
Net cash flows used in investing activities | ( | ( | ( | ( | ||||||
Repurchase of ordinary shares | ( | ( | ( | ( | ||||||
Repayments of long-term debt | ( | ( | ( | ( | ||||||
Net change in revolving credit facilities and short- term debt | ( | |||||||||
Finance lease repayments | ( | ( | ( | ( | ||||||
Transactions with non-controlling interests | ( | ( | ( | ( | ||||||
Other financing activities | ( | ( | ||||||||
Net cash flows used in financing activities | ( | ( | ( | ( | ||||||
Net increase / (decrease) in cash and cash equivalents | ( | |||||||||
Cash and cash equivalents - beginning of period | ||||||||||
Net increase / (decrease) in cash and cash equivalents | ( | |||||||||
Effect of exchange rate changes on cash and cash equivalents | ( | ( | ||||||||
Cash and cash equivalents - end of period | ||||||||||
Three months ended June 30, | Six months ended June 30, | |||||||
(in millions of U.S. dollars) | 2026 | 2025 | 2026 | 2025 | ||||
Aerospace rolled products | ||||||||
Transportation, industry, defense and other rolled products | ||||||||
Packaging rolled products | ||||||||
Automotive rolled products | ||||||||
Specialty and other thin-rolled products | ||||||||
Automotive extruded products | ||||||||
Other extruded products | ||||||||
Total revenue | ||||||||
Three months ended June 30, | ||||||||||
2026 | 2025 | |||||||||
(in millions of U.S. dollars) | A&T | P&ARP | AS&I | H&C (B) | A&T | P&ARP | AS&I | H&C (B) | ||
Segment revenue | ||||||||||
Inter-segment elimination | ( | ( | ( | ( | ( | ( | ||||
External revenue | ||||||||||
Cost of metal | ( | ( | ( | ( | ( | ( | ||||
Production costs | ( | ( | ( | ( | ( | ( | ( | ( | ||
Other segment expenses (A) | ( | ( | ( | ( | ( | ( | ( | ( | ||
Segment Adjusted EBITDA | ( | ( | ||||||||
Six months ended June 30, | ||||||||||
2026 | 2025 | |||||||||
(in millions of U.S. dollars) | A&T | P&ARP | AS&I | H&C (B) | A&T | P&ARP | AS&I | H&C (B) | ||
Segment revenue | ||||||||||
Inter-segment elimination | ( | ( | ( | ( | ( | ( | ||||
External revenue | ||||||||||
Cost of metal | ( | ( | ( | ( | ( | ( | ||||
Production costs | ( | ( | ( | ( | ( | ( | ( | ( | ||
Other segment expenses (A) | ( | ( | ( | ( | ( | ( | ( | ( | ||
Segment Adjusted EBITDA | ( | ( | ||||||||
Three months ended June 30, | Six months ended June 30, | |||||||||
(in millions of U.S. dollars) | Notes | 2026 | 2025 | 2026 | 2025 | |||||
A&T | ||||||||||
P&ARP | ||||||||||
AS&I | ||||||||||
H&C (A) | ( | ( | ( | ( | ||||||
Segment Adjusted EBITDA | ||||||||||
Metal price lag (B) | ( | |||||||||
Depreciation and amortization | ( | ( | ( | ( | ||||||
Impairment of assets | ( | |||||||||
Share based compensation | 16 | ( | ( | ( | ( | |||||
Pension and other post-employment benefits - non-operating gains | ||||||||||
Restructuring costs | ( | ( | ( | ( | ||||||
Unrealized (losses) / gains on derivatives | ( | ( | ||||||||
Unrealized exchange gains / (losses) from the remeasurement of monetary assets and liabilities – net | ||||||||||
Losses on disposal | ( | ( | ( | ( | ||||||
Other (C) | ( | |||||||||
Expenses on factoring arrangements | 8 | ( | ( | ( | ( | |||||
Finance costs – net | 5 | ( | ( | ( | ( | |||||
Income before tax | ||||||||||
Income tax expense | 6 | ( | ( | ( | ( | |||||
Net income | ||||||||||
Three months ended June 30, | Six months ended June 30, | |||||||
(in millions of U.S. dollars) | 2026 | 2025 | 2026 | 2025 | ||||
A&T | ( | ( | ( | ( | ||||
P&ARP | ( | ( | ( | ( | ||||
AS&I | ( | ( | ( | ( | ||||
H&C (A) | ( | ( | ( | ( | ||||
Total capital expenditures (B) | ( | ( | ( | ( | ||||
Three months ended June 30, | Six months ended June 30, | |||||||
(in millions of U.S. dollars) | 2026 | 2025 | 2026 | 2025 | ||||
A&T | ( | ( | ( | ( | ||||
P&ARP | ( | ( | ( | ( | ||||
AS&I | ( | ( | ( | ( | ||||
H&C (A) | ( | ( | ( | ( | ||||
Total depreciation, amortization and impairment expense | ( | ( | ( | ( | ||||
(in millions of U.S. dollars) | At June 30, 2026 | At December 31, 2025 | ||
A&T | ||||
P&ARP | ||||
AS&I | ||||
H&C (A) | ||||
Deferred income tax assets | ||||
Cash and cash equivalents | ||||
Fair value of derivative instruments and other financial assets | ||||
Total assets |
Three months ended June 30, | Six months ended June 30, | |||||||||
(in millions of U.S. dollars) | Notes | 2026 | 2025 | 2026 | 2025 | |||||
Operating income and expenses | ||||||||||
Realized gains / (losses) on derivatives (A) | ( | ( | ||||||||
Unrealized (losses) / gains on derivatives at fair value through profit and loss - net (A) | 12 | ( | ( | |||||||
Unrealized exchange gains / (losses) from the remeasurement of monetary assets and liabilities – net | ||||||||||
Impairment of assets | ( | |||||||||
Restructuring costs | ( | ( | ( | ( | ||||||
Losses on disposal | ( | ( | ( | ( | ||||||
Result from the flood in Valais | 3 | ( | ||||||||
Non-operating income and expenses | ||||||||||
Expenses on factoring arrangements | 8 | ( | ( | ( | ( | |||||
Pension and other post-employment benefits | 13 | |||||||||
Other | ||||||||||
Total other gains and losses - net | ( | ( | ||||||||
Three months ended June 30, | Six months ended June 30, | |||||||||
(in millions of U.S. dollars) | Notes | 2026 | 2025 | 2026 | 2025 | |||||
Interest expense on borrowings (A) | ( | ( | ( | ( | ||||||
Interest expense on finance leases | ( | ( | ( | ( | ||||||
Interest cost on pension and other long-term benefits | 13 | ( | ( | ( | ( | |||||
Realized and unrealized (losses) / gains on debt derivatives at fair value (B) | 12 | ( | ( | ( | ||||||
Realized and unrealized exchange gains / (losses) on financing activities - net (B) | ||||||||||
Other finance expenses | ( | ( | ( | ( | ||||||
Capitalized borrowing costs (C) | ||||||||||
Finance expenses | ( | ( | ( | ( | ||||||
Finance costs - net | ( | ( | ( | ( | ||||||
Three months ended June 30, | Six months ended June 30, | |||||||
(in millions of U.S. dollars except share and per share amounts ) | 2026 | 2025 | 2026 | 2025 | ||||
Numerator: | ||||||||
Net income attributable to equity holders of Constellium SE | ||||||||
Denominator: | ||||||||
Basic - weighted-average ordinary shares outstanding | ||||||||
Dilutive effect of non-vested restricted stock units and performance-based restricted stock units | ||||||||
Diluted - weighted-average ordinary shares, of restricted stock units and performance-based restricted stock units | ||||||||
Basic earnings per share | $ | $ | $ | $ | ||||
Diluted earnings per share | $ | $ | $ | $ | ||||
At June 30, 2026 | At December 31, 2025 | |||
(in millions of U.S. dollars) | Current | Current | ||
Trade receivables - gross | ||||
Allowance for credit losses | ( | ( | ||
Total trade receivables - net | ||||
Total other receivables | ||||
Total trade receivables and other |
(in millions of U.S. dollars) | At June 30, 2026 | At December 31, 2025 | ||
Finished goods | ||||
Work in progress | ||||
Raw materials | ||||
Stores and supplies | ||||
Total inventories |
At June 30, 2026 | At December 31, 2025 | |||
(in millions of U.S. dollars) | Current | Current | ||
Trade payables | ||||
Employees' entitlements | ||||
Other payables | ||||
Total other | ||||
Total trade payables and other |
Six months ended June 30, | ||||
(in millions of U.S. dollars) | 2026 | 2025 | ||
Contract liabilities and other liabilities to customers at January 1, | ||||
Revenue deferred to contract liabilities | ||||
Revenue recognized from contract liabilities | ( | ( | ||
Effect of changes in foreign currency rates and other changes | ( | |||
Contract liabilities and other liabilities to customers at June 30, | ||||
At June 30, 2026 | At December 31, 2025 | |||||||||
(in millions of U.S. dollars) | Nominal Value in Currency | Nominal rate | Effective rate | Face Value | Debt issuance costs | Accrued interest | Carrying value | Carrying value | ||
Secured Pan-U.S. ABL (due 2029) | $ | Floating | ||||||||
Senior Unsecured Notes | ||||||||||
Issued June 2020 and due 2028 | $ | ( | ||||||||
Issued February 2021 and due 2029 | $ | ( | ||||||||
Issued June 2021 and due 2029 | € | ( | ||||||||
Issued August 2024 and due 2032 | $ | ( | ||||||||
Issued August 2024 and due 2032 | € | ( | ||||||||
Finance lease liabilities | ||||||||||
Other loans | ||||||||||
Total debt | ( | |||||||||
Of which non-current | ||||||||||
Of which current (A) | ||||||||||
At June 30, 2026 | At December 31, 2025 | |||||||||||
(in millions of U.S. dollars) | Non- current | Current | Total | Non- current | Current | Total | ||||||
Derivatives that qualify for hedge accounting | ||||||||||||
Currency commercial derivatives | ||||||||||||
Derivatives that do not qualify for hedge accounting | ||||||||||||
Currency commercial derivatives | ||||||||||||
Energy derivatives | ||||||||||||
Metal derivatives | ||||||||||||
Fair value of derivative instruments - assets | ||||||||||||
Derivatives that qualify for hedge accounting | ||||||||||||
Currency commercial derivatives | ||||||||||||
Derivatives that do not qualify for hedge accounting | ||||||||||||
Currency commercial derivatives | ||||||||||||
Energy derivatives | ||||||||||||
Metal derivatives | ||||||||||||
Fair value of derivative instruments - liabilities | ||||||||||||
At June 30, 2026 | At December 31, 2025 | |||||||||||||||
(in millions of U.S. dollars) | Level 1 | Level 2 | Level 3 | Total | Level 1 | Level 2 | Level 3 | Total | ||||||||
Fair value of derivative instruments - assets | ||||||||||||||||
Fair value of derivative instruments - liabilities | ||||||||||||||||
Sold currencies | Maturity Year | Less than 1 year | Over 1 year | |||
USD | 2026-2031 | |||||
CHF | 2026-2030 | |||||
CZK | 2026 | |||||
Other currencies | 2026-2027 |
Purchased currencies | ||||||
USD | 2026-2027 | |||||
CHF | 2026-2030 | |||||
CZK | 2026-2027 | |||||
Other currencies | 2026 |
Three months ended June 30, | Six months ended June 30, | |||||||
(in millions of U.S. dollars) | 2026 | 2025 | 2026 | 2025 | ||||
Derivatives that do not qualify for hedge accounting | ||||||||
Included in Other gains and losses - net | ||||||||
Realized gains on foreign currency derivatives - net (A) | ( | |||||||
Unrealized (losses) / gains on foreign currency derivatives - net (B) | ( | ( | ||||||
Derivatives that qualify for hedge accounting | ||||||||
Included in Other comprehensive income | ||||||||
Unrealized (losses) / gains on foreign currency derivatives - net | ( | ( | ||||||
(Losses) / gains reclassified from cash flow hedge reserve to the Consolidated Income Statement | ( | ( | ( | |||||
Included in Revenue (C) | ||||||||
Realized gains / (losses) on foreign currency derivatives - net (A) | ( | ( | ||||||
Unrealized (losses) / gains on foreign currency derivatives - net | ( | ( | ||||||
Three months ended June 30, | Six months ended June 30, | |||||||
(in millions of U.S. dollars) | 2026 | 2025 | 2026 | 2025 | ||||
Derivatives that do not qualify for hedge accounting | ||||||||
Included in Finance costs - net | ||||||||
Realized gains / (losses) on foreign currency derivatives - net (A) | ( | ( | ( | |||||
Unrealized losses on foreign currency derivatives - net | ( | ( | ( | ( | ||||
Total | ( | ( | ( | |||||
(in millions of U.S. dollars) | Maturity Year | Less than 1 year | Over 1 year | |||
Metal | 2026-2028 | |||||
Natural gas | 2026-2029 |
Three months ended June 30, | Six months ended June 30, | |||||||
(in millions of U.S. dollar) | 2026 | 2025 | 2026 | 2025 | ||||
Derivatives that do not qualify for hedge accounting | ||||||||
Included in Other gains and losses - net | ||||||||
Realized gains / (losses) on commodities derivatives - net (A) | ( | ( | ||||||
Unrealized (losses) / gains on commodities derivatives - net | ( | ( | ( | |||||
Three months ended June 30, | Six months ended June 30, | ||||||||||||
2026 | 2025 | 2026 | 2025 | ||||||||||
(in millions of U.S. dollars) | Pension | OPEB and Other Benefits | Pension | OPEB and Other Benefits | Pension | OPEB and Other Benefits | Pension | OPEB and Other Benefits | |||||
Current service cost | ( | ( | ( | ( | ( | ( | ( | ( | |||||
Interest cost | ( | ( | ( | ( | ( | ( | ( | ( | |||||
Expected return on plan assets | |||||||||||||
Immediate recognition of losses arising over the year | ( | ( | |||||||||||
Amortization of past service gain | |||||||||||||
Amortization of net actuarial gain | |||||||||||||
Total net pension and other long- term benefit cost | ( | ( | ( | ( | ( | ( | |||||||
At June 30, 2026 | At December 31, 2025 | |||||||
(in millions of U.S. dollars) | Current | Non-current | Current | Non-current | ||||
Close down and environmental remediation costs | ||||||||
Restructuring costs | ||||||||
Legal claims and other costs | ||||||||
Total provisions | ||||||||
Three months ended June 30, 2026 | ||||||||
(in millions of U.S. dollars) | Post- employment benefit plans | Cash flow hedges | Currency translation adjustments | Accumulated other comprehensive income / (loss) | ||||
At March 31, 2026 | ( | |||||||
Other comprehensive income / (loss) before reclassification | ( | ( | ( | ( | ||||
Amounts reclassified from accumulated other comprehensive income / (loss) to the income statement | ( | ( | ( | |||||
Amounts reclassified from accumulated other comprehensive income / (loss) to retained earnings | ||||||||
At June 30, 2026 | ( | |||||||
Three months ended June 30, 2025 | ||||||||
(in millions of U.S. dollars) | Post- employment benefit plans | Cash flow hedges | Currency translation adjustments | Accumulated other comprehensive income / (loss) | ||||
At March 31, 2025 | ( | ( | ( | |||||
Other comprehensive income / (loss) before reclassification | ||||||||
Amounts reclassified from accumulated other comprehensive income / (loss) to the income statement | ( | ( | ( | |||||
At June 30, 2025 | ( | |||||||
Six months ended June 30, 2026 | ||||||||
(in millions of U.S. dollars) | Post- employment benefit plans | Cash flow hedges | Currency translation adjustments | Accumulated other comprehensive income / (loss) | ||||
At January 1, 2026 | ( | |||||||
Other comprehensive income / (loss) before reclassification | ( | ( | ( | ( | ||||
Amounts reclassified from accumulated other comprehensive income / (loss) to the income statement | ( | ( | ( | |||||
Amounts reclassified from accumulated other comprehensive income / (loss) to retained earnings | ||||||||
At June 30, 2026 | ( | |||||||
Six months ended June 30, 2025 | ||||||||
(in millions of U.S. dollars) | Post- employment benefit plans | Cash flow hedges | Currency translation adjustments | Accumulated other comprehensive income / (loss) | ||||
At January 1, 2025 | ( | ( | ( | |||||
Other comprehensive income / (loss) before reclassification | ||||||||
Amounts reclassified from accumulated other comprehensive income / (loss) to the income statement | ( | ( | ||||||
Amounts reclassified from accumulated other comprehensive income / (loss) to retained earnings | ||||||||
At June 30, 2025 | ( | |||||||
2026 PSUs | ||
Fair value at grant date (in U.S. dollars) | ||
Share price at grant date (in U.S. dollars) | ||
Dividend yield | ||
Expected volatility (A) | ||
Risk-free interest rate (U.S. government bond yield) |
Three months ended June 30, 2026 | Six months ended June 30, 2026 | |||||||
(as a % of total) | Revenue | Segment Adjusted EBITDA | Revenue | Segment Adjusted EBITDA | ||||
A&T | 25% | 44% | 25% | 42% | ||||
P&ARP | 61% | 53% | 61% | 55% | ||||
AS&I | 17% | 8% | 17% | 9% | ||||
H&C (1) | —% | (5)% | —% | (6)% | ||||
Total | 100% | 100% | 100% | 100% | ||||
Three months ended June 30, | Six months ended June 30, | Percent changes QTD | Percent changes YTD | |||||||||
(U.S. dollars per ton) | 2026 | 2025 | 2026 | 2025 | 2026 vs 2025 | 2026 vs 2025 | ||||||
Average LME transaction price | 3,571 | 2,448 | 3,382 | 2,539 | 46% | 33% | ||||||
Average Midwest premium | 2,518 | 990 | 2,405 | 849 | 154% | 183% | ||||||
Average all-in aluminum price U.S. | 6,089 | 3,438 | 5,787 | 3,388 | 77% | 71% | ||||||
Average LME transaction price | 3,571 | 2,448 | 3,382 | 2,539 | 46% | 33% | ||||||
Average Rotterdam premium | 581 | 195 | 485 | 244 | 198% | 99% | ||||||
Average all-in aluminum price Europe | 4,152 | 2,643 | 3,867 | 2,783 | 57% | 39% | ||||||
Three months ended June 30, | Six months ended June 30, | |||||||||||||||
(in millions of U.S. dollars and as a % of revenue) | 2026 | 2025 | 2026 | 2025 | ||||||||||||
Revenue | 2,748 | 100% | 2,103 | 100% | 5,209 | 100% | 4,082 | 100% | ||||||||
Cost of sales (excluding depreciation and amortization) | (2,268) | 83% | (1,840) | 87% | (4,309) | 83% | (3,556) | 87% | ||||||||
Depreciation and amortization | (84) | 3% | (82) | 4% | (167) | 3% | (160) | 4% | ||||||||
Selling and administrative expenses | (101) | 4% | (88) | 4% | (198) | 4% | (166) | 4% | ||||||||
Research and development expenses | (14) | 1% | (12) | 1% | (27) | 1% | (25) | 1% | ||||||||
Other gains and losses – net | (39) | 1% | 4 | —% | 34 | 1% | (1) | —% | ||||||||
Finance costs – net | (28) | 1% | (29) | 1% | (56) | 1% | (56) | 1% | ||||||||
Income before tax | 214 | 8% | 56 | 3% | 486 | 9% | 118 | 3% | ||||||||
Income tax expense | (66) | 2% | (20) | 1% | (142) | 3% | (44) | 1% | ||||||||
Net income | 148 | 5% | 36 | 2% | 344 | 7% | 74 | 2% | ||||||||
Shipment volumes (in kt) | 381 | n/a | 384 | n/a | 751 | n/a | 756 | n/a | ||||||||
Three months ended June 30, | Six months ended June 30, | |||||||
(in millions of U.S. dollars) | 2026 | 2025 | 2026 | 2025 | ||||
Realized (losses) / gains on foreign currency derivatives - net | (1) | 3 | — | — | ||||
Realized gains / (losses) on commodities derivatives - net | 67 | (28) | 104 | (19) | ||||
Realized gains / (losses) on derivatives | 66 | (25) | 104 | (19) | ||||
Unrealized (losses) / gains on foreign currency derivatives - net | (2) | 23 | (14) | 38 | ||||
Unrealized (losses) / gains on commodities derivatives - net | (100) | 10 | (46) | (17) | ||||
Unrealized (losses) / gains on derivatives at fair value through profit and loss - net | (102) | 33 | (60) | 21 | ||||
Three months ended June 30, | Six months ended June 30, | |||||||||||||||
(in millions of U.S. dollars and as a % of revenue) | 2026 | 2025 | 2026 | 2025 | ||||||||||||
A&T | 680 | 25% | 492 | 23% | 1,289 | 25% | 960 | 24% | ||||||||
P&ARP | 1,680 | 61% | 1,235 | 59% | 3,157 | 61% | 2,422 | 59% | ||||||||
AS&I | 458 | 17% | 421 | 20% | 873 | 17% | 802 | 20% | ||||||||
H&C (1) | 2 | —% | 1 | —% | 3 | —% | 2 | —% | ||||||||
Inter-segment eliminations | (72) | n.m | (46) | n.m | (113) | n.m | (104) | n.m | ||||||||
Total revenue | 2,748 | 100% | 2,103 | 100% | 5,209 | 100% | 4,082 | 100% | ||||||||
Three months ended June 30, | Six months ended June 30, | |||||||||||||||
(in kt and as a % of shipments) | 2026 | 2025 | 2026 | 2025 | ||||||||||||
A&T | 65 | 17% | 53 | 14% | 125 | 17% | 104 | 14% | ||||||||
P&ARP | 266 | 70% | 276 | 72% | 527 | 70% | 545 | 72% | ||||||||
AS&I | 55 | 14% | 55 | 14% | 105 | 14% | 107 | 14% | ||||||||
Inter-segment eliminations | (4) | n.m | — | n.m | (6) | n.m | — | n.m | ||||||||
Total shipments | 381 | 100% | 384 | 100% | 751 | 100% | 756 | 100% | ||||||||
Three months ended June 30, | Six months ended June 30, | |||||||||||||||
(in millions of U.S. dollars and as a % of revenue) | 2026 | 2025 | 2026 | 2025 | ||||||||||||
A&T | 135 | 20% | 84 | 17% | 238 | 18% | 165 | 17% | ||||||||
P&ARP | 165 | 10% | 74 | 6% | 317 | 10% | 135 | 6% | ||||||||
AS&I | 26 | 6% | 18 | 4% | 49 | 6% | 34 | 4% | ||||||||
(in millions of U.S. dollars) | A&T | P&ARP | AS&I | |||
Segment Adjusted EBITDA for the three months ended June 30, 2025 | 84 | 74 | 18 | |||
Volume | 40 | (5) | — | |||
Price and product mix | 16 | 20 | (5) | |||
Costs | (7) | 74 | 12 | |||
Foreign exchange and other | 2 | 2 | 1 | |||
Segment Adjusted EBITDA for the three months ended June 30, 2026 | 135 | 165 | 26 | |||
(in millions of U.S. dollars) | A&T | P&ARP | AS&I | |||
Segment Adjusted EBITDA for the six months ended June 30, 2025 | 165 | 135 | 34 | |||
Volume | 72 | (11) | (4) | |||
Price and product mix | 15 | 47 | (7) | |||
Costs | (23) | 138 | 23 | |||
Foreign exchange and other | 9 | 8 | 3 | |||
Segment Adjusted EBITDA for the six months ended June 30, 2026 | 238 | 317 | 49 |
Six months ended June 30, | ||||
(in millions of U.S. dollars) | 2026 | 2025 | ||
Net Cash Flows from / (used in) | ||||
Operating activities | 234 | 172 | ||
Investing activities | (137) | (131) | ||
Financing activities | (51) | (62) | ||
Net increase / (decrease) in cash and cash equivalents, excluding the effect of exchange rate changes | 46 | (21) | ||
Three months ended June 30, | Six months ended June 30, | |||||||
(in millions of U.S. dollars) | 2026 | 2025 | 2026 | 2025 | ||||
Net income | 148 | 36 | 344 | 74 | ||||
Income tax expense | 66 | 20 | 142 | 44 | ||||
Finance costs – net | 28 | 29 | 56 | 56 | ||||
Expenses on factoring arrangements | 5 | 6 | 9 | 11 | ||||
Depreciation and amortization | 84 | 82 | 167 | 160 | ||||
Restructuring costs | 2 | 1 | 5 | 2 | ||||
Unrealized gains on derivatives | 102 | (33) | 60 | (21) | ||||
Unrealized exchange gains from the remeasurement of monetary assets and liabilities – net | — | (1) | (1) | — | ||||
Pension and other post-employment benefits - non- operating gains | (4) | (4) | (7) | (7) | ||||
Share based compensation | 8 | 7 | 19 | 13 | ||||
Losses on disposal | 1 | 1 | 1 | 1 | ||||
Other (A) | — | 2 | — | (1) | ||||
Adjusted EBITDA1 | 439 | 146 | 798 | 332 | ||||
of which Metal price lag (B) | 129 | (19) | 226 | 20 | ||||
Period | Total number of shares purchased | Average price paid per share (in U.S. dollars) | Total number of shares purchased as part of publicly announced plans or programs | Maximum approximate dollar value of shares that may yet be purchased under the program | ||||
April 1 - April 30, 2026 | 241,155 | 29.74 | 241,155 | 71,669,820 | ||||
May 1 - May 31, 2026(1) | — | — | — | 300,000,000 | ||||
June 1 - June 30, 2026(2) | 381,567 | 34.07 | 381,567 | 287,000,029 | ||||
Total | 622,722 | 622,722 | 287,000,029 |
Exhibit | Description |
31.1 | |
31.2 | |
32.1 | |
32.2 | |
101.INS | Inline XBRL Instance Document** |
101.SCH | Inline XBRL Taxonomy Extension Schema Document** |
101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document** |
101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document** |
101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document** |
101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document** |
104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)** |
Constellium SE | |||
Date: | July 29, 2026 | By: | /s/ Ingrid Joerg |
Name: Ingrid Joerg | |||
Title: Chief Executive Officer and Director | |||
Date: | July 29, 2026 | By: | /s/ Jack Guo |
Name: Jack Guo | |||
Title: Executive Vice President & Chief Financial Officer |